Effect of trichostatin a on SGC-7901 gastric cancer cells

Yun-Long Li1, Tong-Shu Yang2, Wei-Min Ruan1

  • 1Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University Harbin 150081, Heilongjiang Province, China.

Abstract

Insights

Trichostatin A (TSA) induces apoptosis and increases acetylated histone H4 in gastric cancer cells. TSA also down-regulates the glycoprotein hormones alpha subunit (CGA) gene, which is elevated in adenocarcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gastric cancer is a significant global health concern.
  • Understanding the molecular mechanisms of gastric cancer progression is crucial for developing targeted therapies.
  • Trichostatin A (TSA) is a known histone deacetylase inhibitor with potential anti-cancer properties.

Purpose of the Study:

  • To investigate the effects of Trichostatin A (TSA) on SGC-7901 gastric cancer cells.
  • To evaluate TSA's impact on cell growth, apoptosis, and the expression of specific genes and proteins.

Main Methods:

  • Cell viability was assessed using MTT assays.
  • Apoptosis and cell morphology were analyzed via fluorescence microscopy and flow cytometry.
  • Histone acetylation, gene expression (CGA), and protein levels (CGA) were determined using immunocytochemistry, Real-time PCR, Western blot, and microarray assays.
  • CGA protein levels in clinical tissues were examined by immunohistochemistry.

Main Results:

  • TSA significantly inhibited SGC-7901 cell growth and proliferation.
  • TSA treatment led to increased acetylated histone H4 levels and induced apoptosis in gastric cancer cells.
  • TSA down-regulated the expression of the glycoprotein hormones alpha subunit (CGA) gene and protein in SGC-7901 cells.
  • CGA expression was significantly higher in gastric adenocarcinoma tissues compared to normal adjacent tissues.

Conclusions:

  • TSA exhibits anti-cancer effects by inducing apoptosis and increasing histone acetylation in gastric cancer cells.
  • TSA reduces the expression of CGA, a gene that is overexpressed in gastric adenocarcinoma.
  • These findings suggest TSA's potential as a therapeutic agent for gastric cancer, possibly by targeting CGA.

Related Concept Videos